ProMIS Neurosciences
PMN
18 hedge funds and large institutions have $9.24M invested in ProMIS Neurosciences in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
6% more funds holding
Funds holding: 17 → 18 (+1)
0.16% less ownership
Funds ownership: 1.35% → 1.19% (-0.16%)
27% less capital invested
Capital invested by funds: $12.6M → $9.24M (-$3.37M)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HC
Hara Capital
Bellevue,
Washington
|
+$29.3K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Heights Capital Management
San Francisco,
California
|
-$226K |
| 2 |
AC
Armistice Capital
New York
|
-$159K |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$145K |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$38.3K |
| 5 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
-$6.4K |
PMN Hedge Fund Activity: Q4 2024 in Review
18 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q4 2024, worth a combined $9.24M — down 27% from $12.6M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PMN positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 5 trimmed.
The largest buyer was Hara Capital, opening a new position worth an estimated $29.3K. The largest seller was Heights Capital Management, cutting an estimated $226K.
- 18 institutional investors held ProMIS Neurosciences (PMN) as of Q4 2024, up from 17 in Q3 2024.
- Funds reported $9.24M of ProMIS Neurosciences stock for Q4 2024, down 27% quarter-over-quarter.
- 2 funds opened new ProMIS Neurosciences positions in Q4 2024 and 1 closed out, a net change of +1 holder.
- The largest ProMIS Neurosciences buyer in Q4 2024 was Hara Capital, an estimated $29.3K added.
- The largest ProMIS Neurosciences seller in Q4 2024 was Heights Capital Management, an estimated $226K sold.
Based on aggregated 13F filings for Q4 2024.